课题基金 / 基金详情

Basic construction of individual administering design method based on clarification of excretion mechanism of topoisomerase I inhibitor

Basic construction of individual administering design method based on clarification of excretion mechanism of topoisomerase I inhibitor
基于拓扑异构酶I抑制剂排泄机制的个体化给药设计方法的基本构建
批准号:
18590139
负责人:
MIZUTANI Hideki
金额:
$2.44万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2006
资助国家:
日本
项目状态:
已结题
起止时间:
2006 至 2007

项目摘要

项目成果

MIZUTANI Hideki的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
To clarify excretion mechanisms of irinotecan and topotecan, topoisomerase I inhibitors, we investigated the transportation experiment used the cultured cells, the clearance experiment used the rats, and the gene appearance system cell of the drug transporter (hOAT1 cell and hOAT3 cell) was executed. It was clarified that rat internal organs taking clearance (CL) of hydroxy acid form (A-TPT) of topotecan showed a high, internal organs peculiar distribution in order of kidney≒liver>lungs>small intestines≒heart>brain. In addition, the participation of an organic anion transportation system peculiar was suggested in taking of A-TPT. The change was not admitted in transportation in the hOAT1 cell though the transportation of A-TPT in the hOAT3 cell was remarkably promoted compared with the vector cell. In addition, neither the hOAT1 cell nor the hOAT3 cell were promoted as for the transportation of A-TPT. It was thought that OAT3 at least took part from these results in shift of A-TPT partially.The HP100 cell that was the tolerance stock of hydrogen peroxide that was one of the active oxygen species in human culture cell HL-60 and the HL-60 origin was used of the evaluation of the organ damage by irinotecan and topotecan ftom the viewpoint of the apoptosis induction. As a result, it was suggested that hydrogen peroxide take part in the apoptosis of SN-38 and topotecan, and was suggested the existence of the route in activation, as follows : DNA cleavage by irinotecan→rise in cellar level of H_20_2→mitochondria injury→activation of caspase-3→apoptosis induction.It is scheduled that the organ damage by irinotecan and topotecan is evaluated from the viewpoint of the apoptosis induction in addition, the detection method of the organ damage is established, and the role of the drug transporter in the organ damage is verified from the viewpoint of pharmacokinetics and pharmacodynamics in the future.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1111/j.1349-7006.2006.00376.x
发表时间: 2007-02-01
期刊: CANCER SCIENCE
影响因子: 5.7
作者: [Hoki, Yoko, Hiraku, Yusuke, Kawanishi, Shosuke]
通讯作者: Kawanishi, Shosuke
急性期胆汁うっ滞時のシメチジンの体内動態変動における有機カチオントランスポータOCT2の役割
有机阳离子转运蛋白OCT2在急性胆汁淤积期间西咪替丁药代动力学变化中的作用
DOI: --
发表时间: 2008
期刊:
影响因子: --
作者: [清水 寛美, ら, 倉田 朋彦]
通讯作者: 倉田 朋彦
トポイソメラーゼI阻害剤Topotecanの腎輸送における有機アニオントランスポータ3 (OAT3)の関与
有机阴离子转运蛋白 3 (OAT3) 参与拓扑异构酶 I 抑制剂拓扑替康的肾脏转运
DOI: --
发表时间: 2008
期刊:
影响因子: --
作者: [Shimizu T., et. al., 松田紘子]
通讯作者: 松田紘子
iNOS-dependent DNA damage via NF-kappaB expression in hamsters infected with Opisthorchis viverrini and its suppression by the antih elminthic drug praziquantel.
感染 Opisthorchis viverrini 的仓鼠中通过 NF-kappaB 表达造成的 iNOS 依赖性 DNA 损伤及其抗蠕虫药物吡喹酮的抑制。
DOI: --
发表时间: 2006
期刊: Int J Cancer. 119(5)
影响因子: --
作者: [清水 寛美, ら, 渡辺 渡, Pinlaor S]
通讯作者: Pinlaor S
20
    Elucidation of reactive oxygen signaling in the action of anticancer drugs.
    • 批准号:
      25460229
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.16万
    • 财政年份:
      2013
    • 负责人:
      MIZUTANI Hideki
    • 依托单位:
    Study of the occurrence mechanism of adhesion tissues in the temporomandibular joint
    • 批准号:
      11470433
    • 项目类别:
      Grant-in-Aid for Scientific Research (B).
    • 资助金额:
      $3.84万
    • 财政年份:
      1999
    • 负责人:
      MIZUTANI Hideki
    • 依托单位: